Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiopental sodium vs propofol in electroconvulsive therapy
IRCT20160307026950N71Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of thiopental and propofol (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Seizure duration during ECT. Started Sep 2025; status: completed.
02
Drugs
thiopentalpropofol
Beyond the preview
Go deeper on IRCT20160307026950N71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N71.